Open access
The aMAP Score Effectively Stratifies Hepatocellular Carcinoma Risk in the Steatotic Liver Disease Population
Wen-Xin Xu
Ya-Ru Shi
Zhi-Hong Liu
Hong Ma
Jun-Qi Niu
Qing Xie
Jian-Ping Xie
H. Rao
Song Yang
Chun-Xiu Zhong
Xiao-Guang Dou
Dong-Ying Xie
Jun-Hua Yin
Ai-Min Sun
Yong-Feng Yang
Ya-Li Liu
Ya Xu
Qiang Li
Yong-Fang Jiang
Wu Li
Hong Tang
Jian-Qi Lian
Hua-Peng Lin
Jian Sun
Jin-Lin Hou
Rong Fan
Medicine
Abstract
Steatotic liver disease (SLD) is an increasingly important cause of hepatocellular carcinoma (HCC), yet validated risk stratification tools remain limited. We aim to evaluate the aMAP score, initially developed for HCC risk prediction mainly in viral hepatitis across international cohorts, in the SLD population.